Reports
Sale
Global Hemostats Market Size, Trends, Growth, Analysis: By Product Type: Combination, Oxidized Regenerated Cellulose Based, Gelatine Based, Collagen Based Haemostat; By Instrument Type; By Formulation; By Application; By Indication; By End User; By Distribution Channel; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hemostats Market Overview
3.1 Global Hemostats Market Historical Value (2017-2023)
3.2 Global Hemostats Market Forecast Value (2024-2032)
4 Global Hemostats Market Landscape
4.1 Global Hemostats Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hemostats Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Instrument Type
4.2.3 Analysis by Formulation
5 Global Hemostats Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hemostats Market Segmentation (2017-2032)
6.1 Global Hemostats Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Combination
6.1.3 Oxidized Regenerated Cellulose Based
6.1.4 Gelatine Based
6.1.5 Collagen Based Haemostat
6.2 Global Hemostats Market (2017-2032) by Instrument Type
6.2.1 Market Overview
6.2.2 Halstead Mosquito Hemostatic Forceps
6.2.3 Kelly And Crile Hemostatic Forceps
6.2.4 Rochester-Carmalt Hemostatic Forceps
6.3 Global Hemostats Market (2017-2032) by Formulation
6.3.1 Market Overview
6.3.2 Matrix and Gel Hemostats
6.3.3 Sheet and Pad Hemostats
6.3.4 Sponge Hemostats
6.3.5 Powder Hemostats
6.4 Global Hemostats Market (2017-2032) by Application
6.4.1 Market Overview
6.4.2 Orthopaedic
6.4.3 General surgery
6.4.4 Neurological surgery
6.4.5 Cardiovascular surgery
6.4.6 Reconstructive surgery
6.4.7 Gynaecological surgery
6.5 Global Hemostats Market (2017-2032) by Indication
6.5.1 Market Overview
6.5.2 Closure
6.5.3 Surgery
6.6 Global Hemostats Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Ambulatory Centers
6.6.3 Hospitals
6.6.4 Clinics
6.6.5 Community Healthcare
6.6.6 Others
6.7 Global Hemostats Market (2017-2032) by Distribution Channel
6.7.1 Market Overview
6.7.2 Hospitals
6.7.3 Ambulatory Surgical Centers
6.7.4 Clinics
6.7.5 Online Channels
6.8 Global Hemostats Market (2017-2032) by Region
6.8.1 Market Overview
6.8.2 North America
6.8.3 Europe
6.8.4 Asia Pacific
6.8.5 Latin America
6.8.6 Middle East and Africa
7 North America Hemostats Market (2017-2032)
7.1 North America Hemostats Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Combination
7.1.3 Oxidized regenerated cellulose based
7.1.4 Gelatine based
7.1.5 Collagen based haemostat
7.2 North America Hemostats Market (2017-2032) by Instrument Type
7.2.1 Market Overview
7.2.2 Halstead Mosquito Hemostatic Forceps
7.2.3 Kelly And Crile Hemostatic Forceps
7.2.4 Rochester-Carmalt Hemostatic Forceps
7.3 North America Hemostats Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Hemostats Market (2017-2032)
8.1 Europe Hemostats Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Combination
8.1.3 Oxidized regenerated cellulose based
8.1.4 Gelatine based
8.1.5 Collagen based haemostat
8.2 Europe Hemostats Market (2017-2032) by Instrument type
8.2.1 Market Overview
8.2.2 Halstead Mosquito Hemostatic Forceps
8.2.3 Kelly And Crile Hemostatic Forceps
8.2.4 Rochester-Carmalt Hemostatic Forceps
8.3 Europe Hemostats Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Hemostats Market (2017-2032)
9.1 Asia Pacific Hemostats Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Combination
9.1.3 Oxidized regenerated cellulose based
9.1.4 Gelatine based
9.1.5 Collagen based haemostat
9.2 Asia Pacific Hemostats Market (2017-2032) by Instrument type
9.2.1 Market Overview
9.2.2 Halstead Mosquito Hemostatic Forceps
9.2.3 Kelly And Crile Hemostatic Forceps
9.2.4 Rochester-Carmalt Hemostatic Forceps
9.3 Asia Pacific Hemostats Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Others
10 Latin America Hemostats Market (2017-2032)
10.1 Latin America Hemostats Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Combination
10.1.3 Oxidized regenerated cellulose based
10.1.4 Gelatine based
10.1.5 Collagen based haemostat
10.2 Latin America Hemostats Market (2017-2032) by Instrument Type
10.2.1 Market Overview
10.2.2 Halstead Mosquito Hemostatic Forceps
10.2.3 Kelly And Crile Hemostatic Forceps
10.2.4 Rochester-Carmalt Hemostatic Forceps
10.3 Latin America Hemostats Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Hemostats Market (2017-2032)
11.1 Middle East and Africa Hemostats Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Combination
11.1.3 Oxidized regenerated cellulose based
11.1.4 Gelatine based
11.1.5 Collagen based haemostat
11.2 Middle East and Africa Hemostats Market (2017-2032) by Instrument Type
11.2.1 Market Overview
11.2.2 Halstead Mosquito Hemostatic Forceps
11.2.3 Kelly And Crile Hemostatic Forceps
11.2.4 Rochester-Carmalt Hemostatic Forceps
11.3 Middle East and Africa Hemostats Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Pfizer Inc.
17.1.1 Company Overview
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Stryker
17.2.1 Company Overview
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Integra LifeSciences
17.3.1 Company Overview
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Hemostasis, LLC
17.4.1 Company Overview
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Teleflex Incorporated
17.5.1 Company Overview
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic
17.6.1 Company Overview
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 B. Braun SE
17.7.1 Company Overview
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Johnson & Johnson Services, Inc.
17.8.1 Company Overview
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 BD
17.9.1 Company Overview
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Baxter
17.10.1 Company Overview
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Marine Polymer Technologies, Inc.
17.11.1 Company Overview
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Teleflex Incorporated
17.12.1 Company Overview
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Gelita Medical
17.13.1 Company Overview
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Anika Therapeutics, Inc.
17.14.1 Company Overview
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Mil Laboratories Pvt. Ltd.
17.15.1 Company Overview
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Hemostats Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 2.9 billion in 2023, driven by increasing incidence of surgical procedures across the globe.
The market is anticipated to grow at a CAGR of 6.4% during the forecast period of 2024-2032, likely to reach a market value of USD 5.2 billion by 2032.
The market demand is driven by the rising prevalence of road accidents, along with new product launches that cater to a diverse section of indications, along with improvements in the healthcare industry, increasing focus on reducing surgical and post-surgical spending, and the government's reimbursement policies.
The advent of new materials used to improve efficiency of products along with reducing the risk of infection and transmission diseases is the current market trend. For example, Cresilon Inc., launched a new Cresilon Hemostatic Gel (CHG) which incorporates polymers derived from algae plants.
Based on product types, the market is divided into combination, oxidized regenerated cellulose based, gelatine based and collagen-based hemostats.
Matrix and gel, sheet and pad, sponge, and powder are common formulations used in hemostats.
It includes Halstead Mosquito hemostatic forceps, Kelly and Crile hemostatic forceps, and Rochester-Carmalt hemostatic forceps.
Based on indication, it includes closure as well as surgery.
Common application areas include orthopedic, general, neurological, cardiovascular, reconstructive, and gynecological surgeries.
Major distribution channels include hospitals, ambulatory surgical centres, clinics, and online channels.
Major end users include ambulatory centres, hospitals, clinics, community healthcare and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Pfizer Inc., Stryker, Integra LifeSciences, Hemostasis, LLC, Teleflex Incorporated, Medtronic, B. Braun SE, Johnson & Johnson Services, Inc., BD, Baxter, Marine Polymer Technologies, Inc., Teleflex Incorporated, Anika Therapeutics, Inc., and Mil Laboratories Pvt. Ltd., and Gelita Medical.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER